Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1983;24(1):93-8.
doi: 10.1007/BF00613933.

The absolute bioavailability of caffeine in man

J Blanchard, S J Sawers
Free article
Clinical Trial

The absolute bioavailability of caffeine in man

J Blanchard et al. Eur J Clin Pharmacol. .
Free article
Favorites

Abstract

The absolute bioavailability of orally administered caffeine was investigated in 10 healthy adult male volunteers, aged 18.8 to 30.0 years. The subjects were administered a 5 mg/kg dose of caffeine as either an aqueous oral solution or an intravenous infusion, on separate occasions about 1 week apart, in a randomized crossover fashion. Plasma samples were collected over the 24-h period following each dose and assayed for their caffeine content using a high-performance liquid chromatographic technique. The oral absorption was very rapid, reaching a peak (Tp) plasma concentration after 29.8 +/- 8.1 min (mean +/- SEM). In addition, the variation in the maximum plasma concentration (Cmax) was low, 10.0 +/- 1.0 micrograms/ml. The absolute bioavailability was assessed by comparing the areas under the plasma concentration vs. time curves for the intravenous and oral doses of caffeine. The rapid absorption resulted in essentially complete bioavailability of the oral caffeine, F(%) = 108.3 +/- 3.6%. The caffeine plasma half-lives varied from 2.7 to 9.9 h, indicating substantial inter-subject variability in its elimination.

Similar articles

See all similar articles

Cited by 64 articles

See all "Cited by" articles

References

    1. Biochem J. 1973 Jul;134(3):729-36 - PubMed
    1. Life Sci. 1977 Oct 1;21(7):967-74 - PubMed
    1. Clin Chem. 1980 Aug;26(9):1351-4 - PubMed
    1. J Pediatr. 1977 Mar;90(3):467-72 - PubMed
    1. J Pharm Sci. 1981 Jan;70(1):109-12 - PubMed

Publication types

Feedback